Siren, a startup focused on diabetic foot ulcer prevention, has raised $9.5 million in a funding round led by Mölnlycke Health Care. The funding aims to enhance the development of Siren Socks, which monitor foot temperature to detect potential injuries in real-time. With this latest investment, the company has raised a total of $43 million. About 830 million people globally have diabetes, with many at risk for ulcers. Siren's technology claims to reduce the risk of ulcers and amputations significantly, reinforcing its potential impact in the biotech market.